Liver transplantation for aHUS: still needed in the eculizumab era?

Rosanna Coppo; R Bonaudo; Licia Peruzzi; Alessandro Amore; Andrea Brunati; Renato Romagnoli; Mauro Salizzoni; Miriam Galbusera; Eliana Gotti; Erica Daina; Marina Noris; Giuseppe Remuzzi

doi:10.1007/s00467-015-3278-0

Related publications

Article2014

Dynamics of complement activation in aHUS and how to monitor eculizumab therapy

Marina Noris, Miriam Galbusera, Sara Gastoldi, Paolo Macor, Federica Banterla, Elena Bresin, Claudio Tripodo, Serena Bettoni, Roberta Donadelli, Elisabetta Valoti, Francesco Tedesco, Alessandro Amore, Rosanna Coppo, Piero Ruggenenti, Eliana Gotti, Giuseppe Remuzzi

Article2007

Successful Liver-Kidney Transplantation in Two Children With aHUS Caused by a Mutation in Complement Factor H

Hannu Jalanko, Seija Peltonen, Aino Koskinen, Juha Puntila, Helena Isoniemi, C Holmberg, Anne Pinomäki, Elina Armstrong, Anna‐Maria Koivusalo, Eija Tukiainen, Heikki Mäkisalo, Jeffrey M. Saland, Giuseppe Remuzzi, Santiago Rodrı́guez de Córdoba, R. Lassila, Seppo Meri, T. Sakari Jokiranta

Article2023

Residual Thrombosis: Still Relevant in the Direct Oral Anticoagulant (DOAC) Era?

Cecilia Becattini, Giancarlo Agnelli

Article2016

Renal Outcome with Eculizumab in Patients with aHUS with Native and Transplanted Kidneys: Pooled Analysis of 100 Patients.

C. Legendre, Josep M. Campistol, Thorsten Feldkamp, J Wang, Giuseppe Remuzzi, Laurent Weekers, N. Sheerin

Article2002

Pediatric liver transplantation for metabolic diseases

Wanda Petz, Marco Spada, A. Lucianetti, M. Guizzetti, Alessandro Bertani, A Aluffi, Maria Luisa Melzi, P. Stroppa, Silvia Riva, Giuseppe Locatelli, Daniele Alberti, G. La Torre, Giuseppe Remuzzi, Marina Noris, Bruno Gridelli